N-Nitrosodimethylamine

APTIM Ranks in ENR’s Top Three Hazardous Waste Contractors in the U.S.

Retrieved on: 
Thursday, June 22, 2023
ENR, PFAS, Defense, Hazardous waste, Research, N-Nitrosodimethylamine, Rouge, Solvent, Asbestos, Engineering, Groundwater, Architecture, Mathematical Applications Group, Health, Department of Defence, Safety, Environmental remediation

Baton Rouge, La., June 22, 2023 (GLOBE NEWSWIRE) -- The Engineering News-Record’s (ENR) has recognized APTIM as a leader in hazardous waste on the 2023 Top 400 Contractors list.

Key Points: 
  • Baton Rouge, La., June 22, 2023 (GLOBE NEWSWIRE) -- The Engineering News-Record’s (ENR) has recognized APTIM as a leader in hazardous waste on the 2023 Top 400 Contractors list.
  • The professional solutions firm is listed as number three in the Top 20 Hazardous Waste Contractors in the U.S.
  • The Top 400 Contractors list, published annually in May, ranks the 400 largest U.S.-based general contractors on construction contracting-specific annual revenue.
  • The rankings are divided into market categories with hazardous waste defined as “chemical and nuclear waste treatment, asbestos and lead abatement, etc.”

Judge Appoints Four Attorneys to Lead 77,000 Zantac Cancer Cases in Delaware

Retrieved on: 
Wednesday, May 17, 2023
GSK, GSK plc, Monsanto, Superior court, Cancer, N-Nitrosodimethylamine, NDMA, Liability, Wisner, Ranitidine, Case management, Heartburn, FDA, Roundup, Delaware Superior Court, Pharmaceutical industry, Tobacco

Judge Vivian L. Medinilla named Wisner and three others to the leadership position in a Case Management Order that applies to all Zantac (generic: ranitidine) cancer cases currently pending in the Superior Court of the State of Delaware.

Key Points: 
  • Judge Vivian L. Medinilla named Wisner and three others to the leadership position in a Case Management Order that applies to all Zantac (generic: ranitidine) cancer cases currently pending in the Superior Court of the State of Delaware.
  • "We look forward to presenting evidence at trial that Zantac causes cancer, and that the defendants have known about the risks for decades."
  • More than 77,000 people have Zantac lawsuits pending in Delaware state court alleging the widely used heartburn drug contains a known carcinogen called N-nitrosodimethylamine (NDMA).
  • The trial will be closely followed as the allegations in Mr. Goetz's case share many similarities to cases filed in Delaware.

Baum Hedlund Aristei & Goldman is Now Wisner Baum

Retrieved on: 
Tuesday, January 10, 2023
Plaintiff, Transport, Accident, Retirement, Congress, HPV, MDL, Monsanto, County, Philosophy, DOJ, Culture, FDA, Ranitidine, PC, Hain Celestial Group, LLP, Bayer, The National Law Journal, Lawyer, N-Nitrosodimethylamine, NDMA, The American Lawyer, Goldman, Superior court, Dream, Daily, Tobacco, Pharmaceutical industry, Fine chemical, Gardasil, EU

Los Angeles, California, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Baum Hedlund Aristei & Goldman, PC has changed its name to Wisner Baum, LLP.

Key Points: 
  • Los Angeles, California, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Baum Hedlund Aristei & Goldman, PC has changed its name to Wisner Baum, LLP.
  • Vice president R. Brent Wisner , Baum Hedlund’s lead trial attorney, will serve as Wisner Baum’s new managing partner.
  • “I am honored to have the opportunity to lead this firm into its next chapter and eager to continue the legacy that Michael Baum, Paul Hedlund, Clark Aristei, and Ron Goldman built,” says Wisner.
  • 3:22-cv-00397) appointed Wisner Baum senior partner Bijan Esfandiari to serve as co-lead counsel for plaintiffs.

Advisory - One lot of the antidepressant drug APO-Amitriptyline recalled because of nitrosamine impurity

Retrieved on: 
Saturday, April 17, 2021
Ministry of Home Affairs, National Disaster Management Authority, Hepatotoxins, Drugs, N-Nitrosodimethylamine, Organic compounds, Chemical compounds, Ranitidine

This means that long-term exposure to a level above what is considered safe may increase the risk of cancer.

Key Points: 
  • This means that long-term exposure to a level above what is considered safe may increase the risk of cancer.
  • NDMA is not expected to cause harm when ingested at at or below the acceptable level.
  • As this recall affects only one lot, patients are not expected to be exposed to levels of NDMA that exceed safe levels for an extended period of time.
  • Should any additional recalls be deemed necessary, Health Canada will update the table below and inform Canadians.\n"

Valisure Expands Testing Capabilities With The Addition Of Elemental Analysis

Retrieved on: 
Thursday, October 22, 2020
Chemistry, Physical sciences, Natural sciences, Chemical elements, Native element minerals, Endocrine disruptors, Reactive nonmetals, Dietary minerals, N-Nitrosodimethylamine, Arsenic, Chlorine, Selenium

NEW HAVEN, Conn., Oct. 22, 2020 /PRNewswire/ --Valisure announced the addition of elemental analysis for toxic elements to its standard testing methods, which currently includes dosage, major inactive ingredients, dissolution, and analysis for the presence of carcinogens such as N-Nitrosodimethylamine (NDMA).

Key Points: 
  • NEW HAVEN, Conn., Oct. 22, 2020 /PRNewswire/ --Valisure announced the addition of elemental analysis for toxic elements to its standard testing methods, which currently includes dosage, major inactive ingredients, dissolution, and analysis for the presence of carcinogens such as N-Nitrosodimethylamine (NDMA).
  • Valisure's elemental analysis includes testing for 24 of the most common elemental contaminants including lithium, arsenic, mercury, lead, and nickel, among others.
  • "Valisure began implementation of analysis for elemental impurities following the release of recent industry guidance for pharmaceuticals.
  • The early adoption of elemental testing reflects our proactive commitment to quality assurance in the medications that we provide," said Dr. Kaury Kucera, Chief Scientific Officer of Valisure.

Information Update - Ranbaxy Pharmaceuticals Canada Inc. recalls prescription ranitidine products as a precaution; request to stop distribution remains in place while Health Canada continues to assess NDMA

Retrieved on: 
Wednesday, October 30, 2019
Hepatotoxins, Companies, Life sciences, Health, RTT, Amines, H2 receptor antagonists, Furans, Ranitidine, Teva Canada, Sanofi, N-Nitrosodimethylamine

Should any additional recalls be necessary, Health Canada will update the table below and inform Canadians.

Key Points: 
  • Should any additional recalls be necessary, Health Canada will update the table below and inform Canadians.
  • UPDATE: October 18, 2019 - Additional ranitidine products recalled, including Zantac; request to stop distribution remains in place while Health Canada continues to assess NDMA
    Additional prescription and over-the-counter ranitidine drugs, including Zantac, are being recalled by Sanofi Consumer Health Inc., Sivem Pharmaceuticals ULC and Teva Canada Limited because they may contain the impurity N-nitrosodimethylamine (NDMA) above acceptable levels.
  • Companies have agreed with Health Canada's precautionary request to stop distributing all ranitidine drugs in Canada.
  • A complete list of ranitidine products marketed in Canada is available by searching Health Canada's Drug Product Database .

Perrigo Company plc Issues Voluntary Worldwide Recall of Ranitidine Due to Possible Presence of Impurity, N-nitrosodimethylamine (NDMA) Impurity in the product

Retrieved on: 
Wednesday, October 23, 2019
Hepatotoxins, Chemistry, Health, Companies, Nitrosamines, N-Nitrosodimethylamine, RTT, Perrigo, Nitrosamine, NDMA, Ranitidine, National Disaster Management Authority

DUBLIN, Oct. 23, 2019 /PRNewswire/ --As a precautionary measure, Perrigo Company plc (NYSE; TASE: PRGO) announced today that it has initiated a voluntary, worldwide product recall to the retail customer level of ranitidine (all pack sizes).

Key Points: 
  • DUBLIN, Oct. 23, 2019 /PRNewswire/ --As a precautionary measure, Perrigo Company plc (NYSE; TASE: PRGO) announced today that it has initiated a voluntary, worldwide product recall to the retail customer level of ranitidine (all pack sizes).
  • The recall is being taken due to possible presence of a nitrosamine impurity called N-nitrosodimethylamine (NDMA).
  • NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests.
  • Based on the totality of data gathered to date, Perrigo has made the decision to conduct this voluntary recall.

Reflux Gourmet launches MINT CHOCOLATE RESCUE

Retrieved on: 
Friday, October 4, 2019
Chocolate, Hepatotoxins, N-Nitrosodimethylamine, Nitrosamines, Mint chocolate

NAPA, Calif., Oct. 4, 2019 /PRNewswire-PRWeb/ -- Now available on Amazon, Reflux Gourmet offers the benefits of protection and relief from the experience of reflux via its premier product, Mint Chocolate Rescue!

Key Points: 
  • NAPA, Calif., Oct. 4, 2019 /PRNewswire-PRWeb/ -- Now available on Amazon, Reflux Gourmet offers the benefits of protection and relief from the experience of reflux via its premier product, Mint Chocolate Rescue!
  • Mint Chocolate Rescue is safe from the harmful carcinogen N-nitrosodimethylamine, also known as NDMA, which can cause cancer.
  • Unlike other therapeutic options, Reflux Gourmet's Mint Chocolate Rescue actually stops reflux from happening.
  • Now Chef Ken wakes up every day not to pain, but to the answer: Reflux Gourmet's MINT CHOCOLATE RESCUE!

FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity

Retrieved on: 
Tuesday, September 24, 2019
Hepatotoxins, Health, Chemistry, RTT, Physical sciences, Amines, Furans, Ranitidine, Food and Drug Administration, Nitrosamine, N-Nitrosodimethylamine

This recall is due to a nitrosamine impurity , N-nitrosodimethylamine (NDMA), which was found in the recalled medicine.

Key Points: 
  • This recall is due to a nitrosamine impurity , N-nitrosodimethylamine (NDMA), which was found in the recalled medicine.
  • "The FDA is committed to ensuring that the medicines Americans take are safe and effective.
  • We began testing ranitidine products immediately after we learned of the potential impurity.
  • While the FDA investigates the root cause and risk, consumers and patients can continue to take ranitidine that has not been recalled.

Sandoz Inc. Issues Voluntary Recall of Ranitidine Hydrochloride Capsules 150mg and 300mg Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA), in the Product

Retrieved on: 
Tuesday, September 24, 2019
Hepatotoxins, Chemical compounds, Organic compounds, Drugs, RTT, Decongestants, Sandoz, Ranitidine, NDMA, Stericycle, Pseudoephedrine, N-Nitrosodimethylamine

Sandoz Ranitidine Hydrochloride Capsules were distributed nationwide to wholesalers.

Key Points: 
  • Sandoz Ranitidine Hydrochloride Capsules were distributed nationwide to wholesalers.
  • Sandozwill be notifying its distributors and customers via overnight mail and via the Sandoz web site, and will arrange for returnof all recalled products.
  • Pharmacies will be asked to immediately stop dispensing Sandoz Ranitidine Hydrochloride Capsules and return remaining stock to Sandoz by contacting Stericycle to request a recall packet.
  • This recall is being conducted with the knowledge of the U.S. Food and Drug Administration
    View original content to download multimedia: http://www.prnewswire.com/news-releases/sandoz-inc-issues-voluntary-reca...